Fresenius Kabi USA LLC v. Dr Reddy's Laboratories Ltd
1:14-cv-00160
Overview
Parties
Defendant
Dr. Reddy's Laboratories Inc. Operating Company
Represented By
1 Attorneys ListedSmith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
Dr Reddy's Laboratories Ltd Operating Company
Represented By
4 Attorneys ListedSmith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
Plaintiff
Fresenius Kabi USA LLC Operating Company
Represented By
7 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 8,476,010 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| π PCT International (WIPO) | WO 2005007131 A2 | PCT World Application | View Official Patent → |
| πΊπΈ United States | US 9,925,117 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,889,346 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,072,655 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,072,656 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,772,795 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2021012840 | US Continuation / Sibling | View Official Patent → |
Bass, J Kyle et al. v. Fresenius Kabi USA, LLC
Dr. Reddy's Laboratories, Inc. et al. v. Fresenius Kabi USA, LLC
Fresenius Kabi USA, LLC v. B. Braun Medical Inc.
Fresenius Kabi USA LLC v. Claris Lifesciences Ltd.
Fresenius Kabi USA LLC v. Mylan Laboratories Limited
Fresenius Kabi USA LLC v. Watson Laboratories Inc.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8476010
Propofol formulations with non-reactive container closures
|
Filed: 2003-07-10
Issued: 2013-07-02
|
Expired (Term Ended)
+558d PTA
Expires: 2025-01-18
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+558 days) / Cellect Scrutiny β Over 558 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
4
Dispositive
0
Granted
0
Denied
0
Pending / Review
3
Motions by Category
Key Dispositive Motions & Rulings